Trilobio, a pioneering company in laboratory automation solutions, has made waves at the Society for Laboratory Automation and Screening (SLAS) conference in 2025 with the introduction of its comprehensive whole-laboratory automation platform. This groundbreaking unveiling showcased the platform's
Bill Gates' significant role in global health policy, especially through the Bill & Melinda Gates Foundation, raises critical questions about philanthropy's impact on international health and the sustainability of biologics manufacturing. The Foundation is known for its substantial contributions to
The increasing prevalence of Coxsackievirus A6 (CVA6) as a major causative agent for Hand, Foot, and Mouth Disease (HFMD) worldwide necessitates the development of an effective vaccine, especially since there is currently no vaccine available against CVA6 infections. CVA6 infections pose a
Genetic testing for Lynch Syndrome (LS) is crucial in preventing certain cancers, especially for women diagnosed with endometrial (womb) cancer. This inherited condition significantly raises the lifetime risk of various cancers, including bowel, ovarian, pancreatic, and womb cancers. Despite
The transformative impact of technology on public health initiatives and personal health management is undeniable. Advanced tools such as artificial intelligence (AI), big data analytics, wearable devices, and telemedicine are now pivotal in tracking disease outbreaks, personalized health
New York State is actively taking proactive steps to prevent and manage Highly Pathogenic Avian Influenza (HPAI) through heightened monitoring and encouraged testing. This initiative aims at early detection to combat the virus, especially given recent HPAI cases recorded in the wild bird population
In a remarkable advancement for the field of biotechnology, McMaster University and Sartorius have inaugurated a state-of-the-art bioprocessing automation laboratory at the university’s Faculty of Engineering, setting a new standard for bioprocess modeling, simulation, and advanced control. This
The US Food and Drug Administration (FDA) raised serious concerns about Sanofi's manufacturing facility in Framingham, Massachusetts, by issuing a Warning Letter for significant deviations from current Good Manufacturing Practice (cGMP) standards for drug substance production. This alarming
The ethical concerns surrounding the non-disclosure of genetic risks to participants in Alzheimer’s anti-amyloid drug trials have sparked significant debate. Eisai and Eli Lilly, the companies conducting these trials, were aware of the increased risk of brain swelling and bleeding in participants
Randomized controlled trials (RCTs) are the cornerstone of evidence-based medicine, providing the highest level of evidence for the efficacy and safety of new drugs and medical devices. However, traditional RCTs often face significant challenges, including high costs, complex governance, and
